Eighty years since assembly of legendary Soviet monument at 1937 World’s Fair in ParisSociety & Culture May 25, 8:15
Putin receives message clarifying intentions of new South Korean presidentRussian Politics & Diplomacy May 25, 7:47
Forest fires raging on over 8,000 hectares in Russia’s Far East and SiberiaWorld May 25, 6:44
Ukraine’s Savchenko says wants to run for president in 2019World May 25, 3:38
Putin venerates St Nicholas's relics in Cathedral of the SaviorSociety & Culture May 24, 21:53
Putin points out Russia’s good relations with EgyptRussian Politics & Diplomacy May 24, 21:30
Ukraine names conditions for Minsk accords' political part implementationWorld May 24, 20:44
Blaze-stricken Siberian areas expecting downpours that may quash firesSociety & Culture May 24, 19:45
Contact Group on Ukraine proposes more areas of disengagementWorld May 24, 19:39
MOSCOW, March 17. /TASS/. The World Anti-Doping Agency (WADA) still has not answered to the Latvian pharmaceutical firm Grindex why the company’s produced mildronate was included in the list of the banned substances, Grindex spokeswoman Laila Klavina told TASS on Thursday.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016.
"It was last summer, when Grindex jointly with the Anti-Doping Department of the Latvian State Center for Athletics Medicine provided WADA with all arguments, proof and reasoning why the drug should not be included in the list of the banned substances," Klavina said in an interview with TASS.
"There was still no information from WADA last autumn, when it became obvious that meldonium would be on the list," she added. "All we know as of now is that meldonium on the list of the banned substances. Meanwhile, there is still no response from WADA."
Last week Grindex announced on its website that "Mildronate is widely used in the clinical practice."
"During increased physical activity, it restores the oxygen balance of tissue cells as well as it activates the metabolic processes that results in lower requirements of oxygen consumption for energy production," according to Grindex. "Mildronate is widely recognized by health care professionals and patients, and this may include athletes as well."
Russian sports was hit last week by a new case in a chain of doping-related scandals after some of the country’s athletes tested positive for banned substance meldonium.
After the drug meldonium (mildronate) was included in WADA’s list of banned substances a number of Russian athletes tested positive for the banned substance.
Those who have proved to have used meldonium since are cyclist Eduard Vorganov, figure skater Yekaterina Bobrova, tennis player Maria Sharapova, skater Pavel Kulizhnikov, short-track skaters Semion Elistratov and Ekaterina Konstantinova, volleyball player Aleksandr Markin and biathlete Eduard Latypov.
The number of athletes from Russia as well as worldwide testing positive for banned meldonium keeps rising.
The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).